[On the treatment of arteriosclerotic chorioretinopathy].
D000368:Aged; D001161:Arteriosclerosis / Q000150:complications*; D002825:Chorioretinitis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014786:Vision Disorders / Q000209:etiology; D014787:Vision Tests; D014794:Visual Fields; D014970:Xanthines / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014970:Xanthines
Zur Behandlung der arteriosklerotischen Chorioretinopathie.